Literature DB >> 28839858

The financial impact of a nurse-led telemedicine service for inflammatory bowel disease in a large district general hospital.

Seth Ian Squires1, Allan John Boal1, Graham Douglas Naismith1.   

Abstract

INTRODUCTION: It has become increasingly recognised that outpatient management is more cost-effective in inflammatory bowel disease (IBD). IBD Standards (Revised 2013) recommend telephone advice for patients with regard to symptoms and medication management. This report attempts to quantify the net financial impact of this service at our hospital since it was introduced in August 2013.
METHOD: The Royal Alexandra Hospital in Paisley (National Health Service, Greater Glasgow and Clyde) is a district general hospital with a catchment population of 200 000 with approximately 2500 patients with IBD. Data relating to the use of the IBD telemedicine service were prospectively recorded on a daily basis for a period of 5 months. We documented reasons for calling and the likely action taken by the patient had the telephone advice line not been available. Cost savings based on alternative outcomes were made in accordance with the Department of Health figures (Department of Health reference costs 2011-2012).
RESULTS: The mean number of calls per month was 88 (IQR 24)-(the mean number of calls which were deemed non-IBD issues was 30 calls per month (IQR 8.0)) The mean cost of staffing the IBD advice line with an IBD clinical nurse specialist was £482.00 per month (IQR 195.5). The mean time spent on calls per month was 28.5 h (IQR 11.5). Cost savings over 5 months for avoidance of general practitioner (GP) consultation was £3408.00. Savings for avoidance of a consultant appointment made over the 5-month period was £27 454.00. Savings made from patients avoiding either an accident and emergency (A&E) or a hospital admission were £540.00 and £11 488.00, respectively, over the 5-month period. The net saving was £42 890.00.
CONCLUSIONS: A nurse-led telephone advice line appears to be a cost-effective intervention. It may prevent patients from unnecessary hospital attendance. Savings can be made to both primary care and secondary care. Overall, it appears that the advice line is providing a highly valuable service not just in terms of accessible treatment decisions and guidance for patients, but cost savings when IBD clinic nurse specialist time is compared with that of GPs, consultants or hospital facilities.

Entities:  

Keywords:  5-AMINOSALICYLIC ACID (5-ASA); CROHN'S DISEASE; INFLAMMATORY BOWEL DISEASE; ULCERATIVE COLITIS

Year:  2015        PMID: 28839858      PMCID: PMC5369480          DOI: 10.1136/flgastro-2015-100630

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  15 in total

1.  A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease.

Authors:  C Sack; V A Phan; R Grafton; G Holtmann; D R van Langenberg; K Brett; M Clark; J M Andrews
Journal:  J Crohns Colitis       Date:  2011-10-12       Impact factor: 9.071

Review 2.  Methodologies for assessing telemedicine: a systematic review of reviews.

Authors:  Anne G Ekeland; Alison Bowes; Signe Flottorp
Journal:  Int J Med Inform       Date:  2011-11-21       Impact factor: 4.046

3.  Telehealth: Enhancing collaboration, improving care coordination.

Authors:  Donna DeBlois; Mia Millefoglie
Journal:  Nurs Manage       Date:  2015-06

Review 4.  Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States: a review.

Authors:  K T Park; Dorsey Bass
Journal:  Inflamm Bowel Dis       Date:  2010-11-04       Impact factor: 5.325

5.  Establishing an integrated gastroenterology service between a medical center and the community.

Authors:  Yaron Niv; Ram Dickman; Zohar Levi; Gadi Neumann; Dorit Ehrlich; Haim Bitterman; Jacob Dreiher; Arnon Cohen; Doron Comaneshter; Eyran Halpern
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

Review 6.  Distance management of inflammatory bowel disease: systematic review and meta-analysis.

Authors:  Vivian W Huang; Krista M Reich; Richard N Fedorak
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

7.  Exploring the role of the inflammatory bowel disease nurse specialist.

Authors:  Kay Greveson; Sue Woodward
Journal:  Br J Nurs       Date:  2013 Sep 12-25

Review 8.  Second-generation corticosteroids for the treatment of Crohn's disease and ulcerative colitis: more effective and less side effects?

Authors:  Chiara De Cassan; Gionata Fiorino; Silvio Danese
Journal:  Dig Dis       Date:  2012-07-12       Impact factor: 2.404

Review 9.  Twenty years of telemedicine in chronic disease management--an evidence synthesis.

Authors:  Richard Wootton
Journal:  J Telemed Telecare       Date:  2012-06       Impact factor: 6.184

10.  Magical thinking.

Authors:  Charles R Boardman; Amnon Sonnenberg
Journal:  Clin Transl Gastroenterol       Date:  2014-11-13       Impact factor: 4.488

View more
  4 in total

Review 1.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

2.  Implementing a self-management strategy in inflammatory bowel disease (IBD): patient perceptions, clinical outcomes and the impact on service.

Authors:  Seth Ian Squires; Allan John Boal; Selina Lamont; Graham D Naismith
Journal:  Frontline Gastroenterol       Date:  2017-03-29

3.  Specialist inflammatory bowel disease nursing in the UK: current situation and future proofing.

Authors:  Lisa Younge; Isobel Mason; Rukshana Kapasi
Journal:  Frontline Gastroenterol       Date:  2020-04-01

4.  Inflammatory bowel disease patient-reported quality assessment should drive service improvement: a national survey of UK IBD units and patients.

Authors:  A Barney Hawthorne; Jackie Glatter; Jonathan Blackwell; Rachel Ainley; Ian Arnott; Kevin J Barrett; Graham Bell; Matthew J Brookes; Melissa Fletcher; Rafeeq Muhammed; Alan M Nevill; Jonathan Segal; Christian P Selinger; Anja St Clair Jones; Lisa Younge; Christopher A Lamb
Journal:  Aliment Pharmacol Ther       Date:  2022-06-01       Impact factor: 9.524

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.